Caution, This content is for veterinary professionals.
Canigen® Parvo-C
Part of a flexible and convenient vaccine range
Canigen® Parvo-C is an individual component containing canine parvovirus Type 2 (CPV-2)
Product Features & Benefits:
-
Modified live vaccine
-
Protection from 1 week after vaccination
-
At least 3 years duration of immunity
-
Vaccination can start from 4 weeks
-
Strain C154 protects against
-
Types 2, 2b and 2c1
Presentations Available:
Available in 10 doses.
Use medicines responsibly. www.noah.co.uk/responsible.
Further information is available on the SPC or on request from Virbac Ltd.
Related products
Resources